Appili Therapeutics Inc (APLI) — Capital Reinvestment Ratio
Latest as of March 2025:
0.00x
Appili Therapeutics Inc (APLI) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (CA$1.03 Million) in capital expenditures (CA$2.36K). See Appili Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
CA$1.03 Million
CAD
Capital Expenditures
CA$2.36K
CAD
Data as of
Mar 2025
Most recent filing
Appili Therapeutics Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks Appili Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Appili Therapeutics Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for Appili Therapeutics Inc from 2025 to 2025. For live market cap and broader valuation context, see market value of Appili Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CA$868.82K | CA$2.36K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow